Therapy Areas: Inflammatory Diseases
29 July 2021 - Immix Biopharma Inc, a US-based company involved in Tissue Specific Therapeutics for oncology and inflammation, announced on Wednesday that Jane Buchan, PhD is its new director.Dr Bucha...
28 July 2021 - Pulmatrix Inc (NASDAQ: PULM), a clinical-stage biopharmaceutical company, announced on Tuesday that it has appointed Anand Varadan as its new director, effective 26 July 2021.Presently,...
28 July 2021 - - Data from a comparative study conducted by Eurofins Discovery showing commonality between US-based clinical stage pharmaceutical company MyMD Pharmaceuticals, Inc's (NASDAQ:...
28 July 2021 - - US-based biopharmaceutical company Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and US-based immunology focused drug development company Aristea Therapeutics, Inc. have forged a strateg...
27 July 2021 - - US-based biopharmaceutical company Iveric bio, Inc. (NASDAQ: ISEE) has completed patient enrollment of GATHER2, the company's second pivotal clinical trial of Zimura (a...
Related Headlines